SEARCH:   Advanced

Prepublished online as a Blood First Edition Paper on March 6, 2003; DOI 10.1182/blood-2002-10-3245. This Article Abstract Full Text (PDF) All Versions of this Article: 2002-10-3245v1 102/1/142    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Huddleston, H. Articles by Ingram, D. A. Search for Related Content PubMed PubMed Citation Articles by Huddleston, H. Articles by Ingram, D. A. Related Collections Hematopoiesis and Stem Cells Signal Transduction Brief Reports Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 July 2003, Vol. 102, No. 1, pp. 142-145 HEMATOPOIESIS Brief report Functional p85 gene is required for normal murine fetal erythropoiesis Hannah Huddleston, Bailin Tan, Feng-Chun Yang, Hilary White, Mary Jo Wenning, Attilio Orazi, Mervin C. Yoder, Reuben Kapur, and David A. Ingram From the Department of Pediatrics, Indiana University School of Medicine, Herman B Wells Center for Pediatric Research, Indianapolis; and the Department of Hematology/Pathology, Indiana University School of Medicine, Indianapolis.    Abstract Top Abstract Introduction Study design Results and discussion References   In vitro studies suggest that activation of class IA phosphatidylinositol 3 (PI-3) kinase is necessary for normal erythroid cell development. However, when class IA PI-3 kinase–deficient mice were generated by a targeted deletion of the p85 regulatory subunit, fetal erythropoiesis was reportedly unaffected. Given the discrepancies between these studies, we performed a more detailed in vivo analysis of class IA PI-3 kinase–deficient embryos. Day-14.5 p85-/- embryos are pale with a marked reduction of mature erythrocytes in their peripheral blood. Further, the absolute number and frequency of both early (erythroid burst-forming unit [BFU-E]) and late erythroid progenitors (erythroid colony-forming unit [CFU-E]) are reduced in p85-/- fetal livers compared with wild-type controls, which is associated with reduced proliferation. Taken together, these data establish an important role for p85 and class IA PI-3 kinase in regulating the development of both early and late erythroid progenitors in fetal liver. (Blood. 2003;102:142-145)    Introduction Top Abstract Introduction Study design Results and discussion References   Erythropoiesis is a coordinated process regulated by specific signaling pathways. In vitro studies suggest that activation of class IA phosphatidylinositol 3 (PI-3) kinase following binding of erythropoietin (Epo) and kit-ligand (KitL) to their receptors is required for the proliferation, survival, and differentiation of erythroid progenitors.1-10 However, the physiologic role of class IA PI-3 kinase in regulating fetal and adult erythropoiesis is not known. A class IA PI-3 kinase knock-out mouse was generated by a targeted deletion of the p85 regulatory subunit of this kinase.11,12 Although p85-/- mice die shortly after birth secondary to hepatic necrosis and chylous ascites,12 we used p85-/- embryos to investigate the effect of p85 deficiency on fetal liver erythropoiesis in vivo.    Study design Top Abstract Introduction Study design Results and discussion References   Mice and fetal hematopoietic cell isolation p85+/- mice (129/SV x C57BL/6) were obtained from Dr Lewis Cantley at Harvard University (Boston, MA). Studies were conducted with a protocol approved by the Indiana University Animal Care and Use Committee. The p85 allele was genotyped by polymerase chain reaction (PCR) as previously described.11,12 p85+/- mice were mated to produce day-14.5 p85-/- and p85+/+ embryos. Fetal liver cells were isolated as previously described.13 Single cell suspensions were prepared by pushing the hepatic tissues through a 23-gauge needle. Peripheral blood analysis and fetal liver erythropoiesis Embryonic blood was obtained from day-14.5 fetal hearts for peripheral smears, and fetal liver touch preps were performed as previously described14 and stained with Wright-Giemsa (Dade Behring, Newark, DE). Photomicrographs of peripheral smears and touch preps were taken with an Olympus DP11 microscope (Melville, NY). Colony assays Recombinant KitL and Epo were obtained from Peprotech (Rocky Hill, NJ) and Amgen (Thousand Oaks, CA), respectively. Erythroid burst-forming unit (BFU-E) and erythroid colony-forming unit (CFU-E) assays were performed exactly as previously described.15 c-kit+ cell isolation Fetal liver cells were incubated with 1 µg phycoerythrin (PE)–conjugated c-kit monoclonal antibody (Pharmingen, San Diego, CA) per 106 cells, placed on ice for 20 minutes, pelleted, washed, and resuspended in phosphate-buffered saline (PBS). C-kit+ cells were purified by immunomagnetic bead enrichment as previously described.15 Apoptosis and proliferation assays c-kit+ fetal liver cells were stained with fluorescein isothiocyanate (FITC)–annexin V (Pharmingen) and propidium iodide (Sigma, St Louis, MO) exactly per manufacturer's protocol followed by flow cytometric analysis as previously described.16 For thymidine incorporation assays, 10 000 c-kit+ fetal liver cells were plated in 96-well plates in 5% fetal calf serum (BioWhittaker, Walkersville, MD) with Epo and KitL or no growth factors. After 48 hours in culture, cells were pulsed with tritiated thymidine (New Life Sciences, Boston, MA) for 16 to 24 hours and harvested on glass fiber filters, and emission was measured.    Results and discussion Top Abstract Introduction Study design Results and discussion References   To determine the effect of p85 deficiency on fetal liver erythropoiesis, p85+/- mice were intercrossed, and day-14.5 embryos were harvested for analysis. Day-14.5 p85-/- embryos were pale compared with wild-type controls (Figure 1A) and demonstrated a marked reduction in the percentage of mature erythrocytes in their peripheral blood smears (Figure 1B). Most of the circulating cells in the p85-/- embryos were nucleated megaloblasts or megalocytes (79% ± 5% versus 26% ± 8% for wild-type controls, n = 7, P < .05). In contrast, in wild-type peripheral blood, 80% to 90% of circulating cells were enucleated, mature red blood cells, or macrocytes, whereas the remaining cells were yolk sac–derived megaloblasts (Figure 1B). This pattern was also demonstrated in day-14.5 fetal liver touch preps. Although there was a continuum of erythropoiesis in wild-type fetal liver, a predominance of nucleated erythroid precursors was present in p85-/- fetal livers (Figure 1C). View larger version (44K): [in this window] [in a new window]   Figure 1.. Effect of p85 deficiency on fetal liver erythropoiesis in day-14.5 embryos. (A) Phenotypic appearance of wild-type and p85-/- embryos at day 14.5 of gestation. p85-/- embryos are pale compared with wild-type controls. Original magnification, x 10. (B) Representative peripheral blood smears from day-14.5 wild-type and p85-/- embryos. Blood smears were stained with Wright-Giemsa, and the total number of mature erythrocytes was quantified ("Results and discussion"). Mature erythrocytes (macrocytes) are indicated by black arrows, yolk sac–derived megaloblasts are indicated by short open arrows, and fetal liver-derived erythroid precursors are indicated by red arrows. p85-/- peripheral blood contains fewer nonnucleated red cells and a large number of nucleated erythroblasts. Original magnification, x 40. (C) Representative fetal liver touch preps from wild-type and day-14.5 p85-/- embryos. Touch preps were stained with Wright-Giemsa. Numerous erythropoietic cells in all stages of differentiation are observed in wild-type fetal livers. More megaloblasts are observed in the fetal livers of p85-/- embryos (short open arrows). Original magnification, x 40. (D) Total number of BFU-Es and CFU-Es in day-14.5 wild-type () and p85-/- () fetal livers. Cells were plated for growth of BFU-Es in methylcellulose medium containing various concentrations of KitL as indicated combined with a single concentration of Epo (5 U/mL). Cells were plated for growth of CFU-Es in methylcellulose medium containing various concentrations of Epo alone as indicated. CFU-Es and BFU-Es were counted by indirect microscopy after 2 and 7 days of culture, respectively. Results represent the mean number of colonies per fetal liver ± SEM of 5 independent experiments. *P < .05 by Student paired t test. (E) Frequency of erythroid progenitors in c-kit+–sorted fetal liver cells isolated from day-14.5 p85-/- () and wild-type () fetal livers. c-kit+ cells were isolated by immunomagnetic bead enrichment and sorted as previously described.15 More than 90% of the cells were c-kit+ after sorting as tested by fluorescence cytometry (data not shown). c-kit+ cells/mL (2000) were plated in methylcellulose medium containing KitL (10 ng/mL) and Epo (5 U/mL), and the numbers of CFU-Es and BFU-Es were quantified after 2 and 7 days of culture, respectively. In addition, 2000 c-kit+ cells/mL were plated in methylcellulose medium containing Epo (5 U/mL) alone, and the number of CFU-Es was counted after 2 days of culture. Results represent the mean number of colonies per 2000 c-kit+ cells ± SEM of 3 independent experiments. *P < .05 by Student paired t test.   We next assayed for early (BFU-E) and late (CFU-E) erythroid progenitors in wild-type and p85-/- fetal livers. A marked reduction in the total number of BFU-E and CFU-E progenitors was observed in p85-/- fetal livers compared with wild-type controls (Figure 1D). The reduction in BFU-Es and CFU-Es in p85-/- fetal livers could be secondary to p85 deficiency in hematopoietic progenitors or alternatively a defect in the p85-/- microenvironment. To directly test the effect of p85 deficiency on erythroid colony formation independent of the effects of the microenvironment, we performed BFU-E and CFU-E assays with equal numbers of sorted wild-type and p85-/- c-kit+ cells, which are enriched for hematopoietic progenitors. A marked reduction in the frequency of both BFU-Es and CFU-Es was observed in c-kit+ cells isolated from day-14.5 p85-/- fetal livers compared with wild-type controls (Figure 1E). Interestingly, the reduction in CFU-E frequency observed in p85-/- c-kit+ cells was significantly greater when cells were stimulated with both KitL and Epo in combination compared with Epo alone (Figure 1E). Collectively, these results argue that an intrinsic p85-/- hematopoietic progenitor cell defect contributes in part to the reduction of erythroid progenitors in day-14.5 p85-/- fetal livers in vivo and the lack of mature erythrocytes in the peripheral blood of these affected fetuses. Because these data establish a previously unrecognized role for p85 in regulating fetal erythropoiesis in vivo, we next tested whether the p85-/- erythroid phenotype could be linked to either a decrease in proliferation and/or survival of hematopoietic progenitors. Prior studies argue that activation of the PI-3 kinase/Akt pathway by either Epo or KitL promotes the survival of erythroid progenitors.1,6,8,17 To test this hypothesis in vivo, we compared the percentage of both freshly isolated c-kit+ cells (a marker for early erythroid progenitors) or ter119+ cells (a marker for late erythroid progenitors) undergoing apoptosis harvested from wild-type and p85-/- day-14.5 fetal livers. Cells were stained with annexin to identify apoptotic cells. No differences in apoptosis in either c-kit+ or ter119+ cells isolated from the 2 experimental genotypes were observed (Figure 2A). These data are consistent with 2 recent reports which show that p85-/- mast cells do not have an increase in apoptosis in response to KitL compared with wild-type controls.18,19 View larger version (37K): [in this window] [in a new window]   Figure 2.. Apoptosis and proliferation of wild-type and p85-/- c-kit+ fetal liver cells. (A) Apoptosis of wild-type and p85-/- c-kit+ or ter119+ day-14.5 fetal liver cells. Freshly isolated fetal liver cells were stained with either annexin V–PE or c-kit–FITC antibodies to identify the percentage of c-kit+ cells (top row) or annexin V–FITC and ter119-PE antibodies (bottom row) to identify the percentage of ter119+ cells undergoing apoptosis by fluorescence cytometry in vivo. The numbers in each quadrant represent the percentage of total cells in that quadrant. A representative dot plot for each genotype is shown. Four other experiments showed similar results. (B) Proliferation of wild-type () and p85-/- () c-kit+ day-14.5 fetal liver cells in response to no growth factors, Epo and KitL in combination, or alone. Freshly isolated c-kit+ fetal liver cells were plated in 96-well plates in replicates of 6 in the presence of 5% fetal calf serum with no additional growth factors or 10 ng/mL KitL and 5 U/mL Epo in combination or alone. After 48 hours of culture, cells were pulsed with tritiated thymidine and harvested 16 hours later for measurement of emission. Results represent the mean thymidine incorporation ± SEM of 5 independent experiments. *P < .05 by Student paired t test.   We next tested whether p85 deficiency would alter the proliferation of c-kit+ progenitor cells in response to either KitL or Epo alone or in combination. Remarkably, p85-/- c-kit+ cells displayed a 40% to 50% reduction in proliferation in response to KitL alone or KitL in combination with Epo compared with wild-type cells (Figure 2B). Such a proliferative defect would account for the diminished number of erythroid progenitors measured in the day-14.5 p85-/- embryos. This finding would explain why knock-in mice harboring a mutation in the p85 binding domain of the c-kit receptor are not anemic as adult animals,20 whereas we note an erythropoietic defect in p85-/- fetal livers. It is well known that rates of hematopoietic progenitor proliferation are approximately 2-fold higher in fetal liver compared with adult bone marrow under normal homeostatic conditions.21 Thus, a defect in basal and stimulated progenitor proliferation would affect fetal liver more than adult hematopoiesis. Further, other hematopoietic growth factors or integrins may act in synergy with KitL to transmit signals via class IA PI-3 kinase to augment the proliferation of erythroid progenitors. This situation would result in a more anemic phenotype in p85-/- animals compared with mice containing only a mutation in the p85 binding site of the c-kit receptor. Finally, p85-/- c-kit+ cells stimulated with Epo alone demonstrated only a 10% reduction in proliferation compared with wild-type cells (Figure 2B). This finding is consistent with the observation that mutant mice harboring an Epo receptor, which lacks the p85 binding site, are viable with relatively normal adult erythropoiesis.22 This observation is also consistent with our clonogenic data, which showed that p85-/- c-kit+ cells had only a minor decrease in CFU-E formation in response to Epo alone (Figure 1E). Thus, these studies clearly establish and clarify a role for p85 and class IA PI-3 kinase in regulating normal fetal erythropoiesis in vivo at least in part by promoting the proliferation of hematopoietic progenitors via signaling through the KitL/c-kit pathway. Our studies did not find a role for p85 in controlling the survival of c-kit+ cells in vivo. However, Akt activation in p85-/- c-kit+ cells in response to either Epo or KitL was reduced by only 30% to 40% compared with wild-type controls (data not shown), which is consistent with previous studies using other primary p85-/- cell lines stimulated with different growth factors.11,12,18,19,23 The retention of a significant amount of Akt activity in our p85-/- cells may explain the differences in our results and previous in vitro studies using pharmacologic inhibitors of PI-3 kinase. Future studies designed to further reduce class IA PI-3 kinase activity in vivo in genetically engineered animal models will clarify the role of this kinase in regulating both fetal and adult erythropoiesis.    Acknowledgements   We thank Dr Lewis Cantley for providing p85+/- mice, Marsha Hippensteel for exceptional administrative support, and Drs L. Haneline and D. Clapp (Indiana University) for many valuable discussions and thoughtful review of the manuscript.    Footnotes   Submitted October 25, 2002; accepted February 21, 2003. Prepublished online as Blood First Edition Paper, March 6, 2003; DOI 10.1182/blood-2002-10-3245. Supported by grants 1 KO8 CA096579 [GenBank] -01 (D.A.I.) and R01HL63169 (M.C.Y.) from the National Institutes of Health and by grant P30 DK49218 (D.A.I.) from the National Institute of Diabetes and Digestive and Kidney Diseases. H.H. is a Howard Hughes Medical Institute Medical Student Research Training Fellow. D.A.I. is a recipient of a Basil O'Connor Award from the March of Dimes (5-FY02-254). The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. Reprints: David A. Ingram, Indiana University School of Medicine, Herman B. Wells Center for Pediatric Research, 1044 W Walnut St, R4/470, Indianapolis, IN 46202; e-mail: dingram{at}iupui.edu.    References Top Abstract Introduction Study design Results and discussion References   Somervaille TC, Linch DC, Khwaja A. Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood. 2001;98: 1374-1381.[Abstract/Free Full Text] Kubota Y, Tanaka T, Kitanaka A, et al. Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase. EMBO J. 2001;20: 5666-5677.[CrossRef][Medline] [Order article via Infotrieve] Klingmuller U, Wu H, Hsiao JG, et al. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci U S A. 1997;94: 3016-3021.[Abstract/Free Full Text] Verdier F, Chretien S, Billat C, Gisselbrecht S, Lacombe C, Mayeux P. Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2: an alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation. J Biol Chem. 1997;272: 26173-26178.[Abstract/Free Full Text] Lecoq-Lafon C, Verdier F, Fichelson S, et al. Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase. Blood. 1999;93: 2578-2585.[Abstract/Free Full Text] Bao H, Jacobs-Helber SM, Lawson AE, Penta K, Wickrema A, Sawyer ST. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood. 1999;93: 3757-3773.[Abstract/Free Full Text] Barnache S, Mayeux P, Payrastre B, Moreau-Gachelin F. Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts. Blood. 2001;98: 2372-2381.[Abstract/Free Full Text] Haseyama Y, Sawada K, Oda A, et al. Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood. 1999;94: 1568-1577.[Abstract/Free Full Text] Sui X, Krantz SB, You M, Zhao Z. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood. 1998;92: 1142-1149.[Abstract/Free Full Text] Linnekin D. Early signaling pathways activated by c-Kit in hematopoietic cells. Int J Biochem Cell Biol. 1999;31: 1053-1074.[CrossRef][Medline] [Order article via Infotrieve] Fruman DA, Snapper SB, Yballe CM, et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85a. Science. 1999;283: 393-397.[Abstract/Free Full Text] Fruman DA, Mauvais-Jarvis F, Pollard DA, et al. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85a. Nat Genet. 2000;26: 379-382.[CrossRef][Medline] [Order article via Infotrieve] Zhang YY, Vik TA, Ryder JW, et al. Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines. J Exp Med. 1998;187: 1893-1902.[Abstract/Free Full Text] Mucenski ML, McLain K, Kier AB, et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 1991;65: 677-689.[CrossRef][Medline] [Order article via Infotrieve] Yoder MC, Hiatt K, Dutt P, Mukherjee P, Bodine DM, Orlic D. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity. 1997;7: 335-344.[CrossRef][Medline] [Order article via Infotrieve] Kapur R, Zhang L. A novel mechanism of cooperation between c-Kit and erythropoietin receptor: stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin. J Biol Chem. 2001;276: 1099-1106.[Abstract/Free Full Text] Nishigaki K, Hanson C, Ohashi T, Thompson D, Muszynski K, Ruscetti S. Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins. J Virol. 2000; 74: 3037-3045.[Abstract/Free Full Text] Fukao T, Yamada T, Tanabe M, et al. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat Immunol. 2002;3: 295-304.[CrossRef][Medline] [Order article via Infotrieve] Lu-Kuo JM, Fruman DA, Joyal DM, Cantley LC, Katz HR. Impaired kit- but not FcepsilonRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85a gene products. J Biol Chem. 2000;275: 6022-6029.[Abstract/Free Full Text] Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, Hunter T. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3'-kinase is essential for male fertility. Nat Genet. 2000;24: 157-162.[CrossRef][Medline] [Order article via Infotrieve] Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol. 1993;122: 897-902.[Abstract/Free Full Text] Zang H, Sato K, Nakajima H, McKay C, Ney PA, Ihle JN. The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis. EMBO J. 2001;20: 3156-3166.[CrossRef][Medline] [Order article via Infotrieve] Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol. 2002;22: 965-977.[Abstract/Free Full Text] CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: Y. Zhang, E. Diaz-Flores, G. Li, Z. Wang, Z. Kang, E. Haviernikova, S. Rowe, C.-K. Qu, W. Tse, K. M. Shannon, et al. Abnormal hematopoiesis in Gab2 mutant mice Blood, July 1, 2007; 110(1): 116 - 124. [Abstract] [Full Text] [PDF] W. J. Bakker, T. B. van Dijk, M. Parren-van Amelsvoort, A. Kolbus, K. Yamamoto, P. Steinlein, R. G. W. Verhaak, T. W. Mak, H. Beug, B. Lowenberg, et al. Differential Regulation of Foxo3a Target Genes in Erythropoiesis Mol. Cell. Biol., May 15, 2007; 27(10): 3839 - 3854. [Abstract] [Full Text] [PDF] H. K. Bone and M. J. Welham Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis J. Cell Sci., May 15, 2007; 120(10): 1752 - 1762. [Abstract] [Full Text] [PDF] W. F. Khalaf, F.-C. Yang, S. Chen, H. White, W. Bessler, D. A. Ingram, and D. W. Clapp K-ras Is Critical for Modulating Multiple c-kit-Mediated Cellular Functions in Wild-Type and Nf1+/- Mast Cells J. Immunol., February 15, 2007; 178(4): 2527 - 2534. [Abstract] [Full Text] [PDF] S. Ghaffari, C. Kitidis, W. Zhao, D. Marinkovic, M. D. Fleming, B. Luo, J. Marszalek, and H. F. Lodish AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation Blood, March 1, 2006; 107(5): 1888 - 1891. [Abstract] [Full Text] [PDF] L. S. Haneline, H. White, F.-C. Yang, S. Chen, C. Orschell, R. Kapur, and D. A. Ingram Genetic reduction of class IA PI-3 kinase activity alters fetal hematopoiesis and competitive repopulating ability of hematopoietic stem cells in vivo Blood, February 15, 2006; 107(4): 1375 - 1382. [Abstract] [Full Text] [PDF] W. Zhao, C. Kitidis, M. D. Fleming, H. F. Lodish, and S. Ghaffari Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway Blood, February 1, 2006; 107(3): 907 - 915. [Abstract] [Full Text] [PDF] M. A. Sanz, M. S. Tallman, and F. Lo-Coco Practice Points, Consensus, and Controversial Issues in the Management of Patients with Newly Diagnosed Acute Promyelocytic Leukemia Oncologist, November 1, 2005; 10(10): 806 - 814. [Abstract] [Full Text] [PDF] K. Tachibana, N. Jones, D. J. Dumont, M. C. Puri, and A. Bernstein Selective Role of a Distinct Tyrosine Residue on Tie2 in Heart Development and Early Hematopoiesis Mol. Cell. Biol., June 1, 2005; 25(11): 4693 - 4702. [Abstract] [Full Text] [PDF] W. F. Khalaf, H. White, M. J. Wenning, A. Orazi, R. Kapur, and D. A. Ingram K-Ras is essential for normal fetal liver erythropoiesis Blood, May 1, 2005; 105(9): 3538 - 3541. [Abstract] [Full Text] [PDF] M. J. Weiss New Insights Into Erythropoietin and Epoetin Alfa: Mechanisms of Action, Target Tissues, and Clinical Applications Oncologist, December 1, 2003; 8(90003): 18 - 29. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) All Versions of this Article: 2002-10-3245v1 102/1/142    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Huddleston, H. Articles by Ingram, D. A. Search for Related Content PubMed PubMed Citation Articles by Huddleston, H.